Ullem Scott B.
SEC CIK 1446989 · EDGAR
BoughtSold
Most active insiders at ILMN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meister Keith A. | Dir | — | $591.13M |
| 2 | Davies Scott M | CLO | — | $531.3K |
| 3 | Leckman Patricia | SVP, CHRO | — | $529.7K |
| 4 | Wedel Christensen Jakob | SVP, Strategy, Corp Development | — | $366.1K |
| 5 | Ericksen Scott D | VP, CAO | — | $305.1K |
| 6 | Gottlieb Scott | Dir | $84.6K | — |
| 7 | Sullivan Michael C | Chief Commercial Off | — | — |
| 8 | Barnard Steven | SVP, CTO | — | — |
| 9 | Pegels Kevin Carl | Chief of Gbl Ops | — | — |
| 10 | Dhingra Ankur | SVP, CFO | — | — |
| 14 | Ullem Scott B. | Dir | — | — |
Transactions 92
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 18:22 | 2026-06-30 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $149.19 | +167 | 11.0K | +2% | +$24.9K | |
| 2026-05-22 17:14 | 2026-05-21 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $144.83 | +2,072 | 10.9K | +24% | +$300.1K | |
| D | 2026-05-11 21:59 | 2026-05-11 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | +19.8K | 57.7K | +52% | $0 |
| D | 2026-05-11 21:59 | 2026-05-11 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $79.96 | -11.0K | 46.7K | -19% | -$879.9K |
| M | 2026-05-08 21:16 | 2026-05-07+ | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $82.96 | -3,034 | 37.9K | -7% | -$251.7K |
| DM | 2026-05-05 19:08 | 2026-05-03+ | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $82.97 | -11.8K | 40.9K | -22% | -$974.9K |
| D | 2026-05-05 19:08 | 2026-05-05 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.1K | +33% | +$770.3K |
| DT | 2026-04-09 19:34 | 2026-04-09 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.7K | +33% | +$770.3K |
| DMT | 2026-04-09 19:34 | 2026-04-09 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $80.04 | -13.0K | 39.7K | -25% | -$1.04M |
| 2026-04-02 18:32 | 2026-03-31 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $131.55 | +190 | 8,791 | +2% | +$25.0K | |
| DM | 2026-03-11 | 2026-03-11 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $84.92 | -13.0K | 47.6K | -21% | -$1.10M |
| D | 2026-03-11 | 2026-03-11 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.7K | +33% | +$770.4K |
| 2026-02-17 | 2026-02-16 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $75.87 | -199 | 39.7K | -0.5% | -$15.1K | |
| 2026-01-05 | 2025-12-31 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $117.63 | +212 | 8,601 | +3% | +$24.9K | |
| D | 2025-12-09 | 2025-12-09 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +7,700 | 47.6K | +19% | +$456.3K |
| D | 2025-12-09 | 2025-12-09 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $84.47 | -7,700 | 39.9K | -16% | -$650.4K |
| D | 2025-11-10 | 2025-11-10 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.9K | +33% | +$770.4K |
| DM | 2025-11-10 | 2025-11-10 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $83.08 | -13.0K | 39.9K | -25% | -$1.08M |
| 2025-10-02 | 2025-09-30 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $99.17 | +252 | 8,389 | +3% | +$25.0K | |
| 2025-07-02 | 2025-06-30 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $81.20 | +307 | 8,137 | +4% | +$24.9K | |
| 2025-05-23 | 2025-05-21 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $0.00 | +3,780 | 7,830 | +93% | $0 | |
| 2025-05-20 | 2025-05-16 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | F - Tax | $83.62 | -1,070 | 4,050 | -21% | -$89.5K | |
| 2025-05-12 | 2025-05-11 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $73.68 | -1,200 | 39.9K | -3% | -$88.4K | |
| D | 2025-05-09 | 2025-05-09 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $74.40 | -11.2K | 41.1K | -21% | -$837.0K |
| D | 2025-05-09 | 2025-05-09 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +11.2K | 52.3K | +27% | +$509.4K |
| D | 2025-05-09 | 2025-05-07 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $74.92 | -1,406 | 27.7K | -5% | -$105.3K |
| D | 2025-05-09 | 2025-05-08 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | A - Grant | $0.00 | +13.4K | 41.1K | +48% | $0 |
| M | 2025-05-05 | 2025-05-03+ | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $75.65 | -1,283 | 29.1K | -4% | -$97.1K |
| 2025-04-01 | 2025-03-31 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $104.92 | +229 | 5,120 | +5% | +$24.0K | |
| D | 2025-03-26 | 2025-03-26 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +11.2K | 41.6K | +37% | +$509.4K |
| D | 2025-03-26 | 2025-03-26 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $70.87 | -11.2K | 30.4K | -27% | -$797.3K |
| DM | 2025-02-28 | 2025-02-28 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $70.79 | -11.2K | 30.4K | -27% | -$796.4K |
| D | 2025-02-28 | 2025-02-28 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +11.2K | 41.6K | +37% | +$509.4K |
| 2025-02-18 | 2025-02-16 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $76.19 | -174 | 30.4K | -0.6% | -$13.3K | |
| D | 2025-02-13 | 2025-02-13 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +11.2K | 41.8K | +37% | +$509.4K |
| D | 2025-02-13 | 2025-02-13 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $75.76 | -11.2K | 30.6K | -27% | -$852.3K |
| 2025-01-02 | 2024-12-31 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $142.06 | +158 | 4,891 | +3% | +$22.4K | |
| D | 2024-12-09 | 2024-12-09 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $71.68 | -11.2K | 30.6K | -27% | -$806.4K |
| D | 2024-12-09 | 2024-12-09 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +11.2K | 41.8K | +37% | +$509.4K |
| 2024-10-01 | 2024-09-30 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $122.78 | +183 | 4,733 | +4% | +$22.5K | |
| 2024-07-01 | 2024-06-28 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $109.65 | +205 | 4,550 | +5% | +$22.5K | |
| D | 2024-06-20 | 2024-06-20 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +5,625 | 36.2K | +18% | +$254.7K |
| DM | 2024-06-20 | 2024-06-20 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $87.52 | -5,625 | 30.6K | -16% | -$492.3K |
| D | 2024-05-21 | 2024-05-21 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +5,625 | 36.2K | +18% | +$254.7K |
| D | 2024-05-21 | 2024-05-21 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $90.45 | -5,625 | 30.6K | -16% | -$508.8K |
| 2024-05-17 | 2024-05-16 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $0.00 | +2,622 | 4,292 | +157% | $0 | |
| 2024-05-13 | 2024-05-11 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $86.72 | -1,198 | 30.6K | -4% | -$103.9K | |
| D | 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | A - Grant | $0.00 | +11.1K | 32.5K | +52% | $0 |
| D | 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $85.09 | -790 | 31.8K | -2% | -$67.2K |
| DM | 2024-05-06 | 2024-05-03+ | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $85.23 | -5,065 | 18.4K | -22% | -$431.7K |
| D | 2024-05-06 | 2024-05-04 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | +7,465 | 25.9K | +40% | $0 |
| D | 2024-04-30 | 2024-04-30 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,250 | 26.3K | +38% | +$266.4K |
| DM | 2024-04-30 | 2024-04-30 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $85.80 | -7,250 | 19.1K | -28% | -$622.1K |
| 2024-04-02 | 2024-03-28 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $137.68 | +163 | 1,670 | +11% | +$22.4K | |
| D | 2024-04-01 | 2024-04-01 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.3K | +38% | +$266.6K |
| DM | 2024-04-01 | 2024-04-01 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $94.89 | -7,255 | 25.5K | -22% | -$688.5K |
| D | 2024-02-29 | 2024-02-29 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.3K | +38% | +$266.6K |
| D | 2024-02-29 | 2024-02-29 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $85.59 | -7,255 | 19.1K | -28% | -$621.0K |
| 2024-02-16 | 2024-02-16 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $86.04 | -174 | 19.1K | -0.9% | -$15.0K | |
| D | 2024-02-01 | 2024-02-01 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2024-02-01 | 2024-02-01 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $78.29 | -7,255 | 19.2K | -27% | -$568.0K |
| D | 2023-12-29 | 2023-12-29 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $76.55 | -14.5K | 19.2K | -43% | -$1.11M |
| D | 2023-12-29 | 2023-12-29 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +14.5K | 33.8K | +75% | +$533.2K |
| D | 2023-10-31 | 2023-10-31 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-10-31 | 2023-10-31 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $62.66 | -7,255 | 19.2K | -27% | -$454.6K |
| D | 2023-09-29 | 2023-09-29 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $69.54 | -7,255 | 19.2K | -27% | -$504.5K |
| D | 2023-09-29 | 2023-09-29 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-08-31 | 2023-08-31 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-08-31 | 2023-08-31 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $77.79 | -7,255 | 19.2K | -27% | -$564.4K |
| D | 2023-07-31 | 2023-07-31 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-07-31 | 2023-07-31 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $84.35 | -7,255 | 19.2K | -27% | -$612.0K |
| D | 2023-06-30 | 2023-06-30 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-06-30 | 2023-06-30 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $93.27 | -7,255 | 19.2K | -27% | -$676.7K |
| 2023-06-06 | 2023-06-01 | ILMN | ILLUMINA, INC. | Ullem Scott B. | Dir | A - Grant | $0.00 | +1,507 | 1,507 | New | $0 | |
| 2023-05-17 | 2023-05-17 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | G - Gift | $0.00 | -8,496 | 19.2K | -31% | $0 | |
| I | 2023-05-17 | 2023-05-17 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | G - Gift | $0.00 | +8,496 | 266.3K | +3% | $0 |
| D | 2023-05-15 | 2023-05-11 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | A - Grant | $0.00 | +9,450 | 27.7K | +52% | $0 |
| DM | 2023-05-11 | 2023-05-10 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | S - Sale+OE | $88.54 | -80.7K | 18.3K | -82% | -$7.14M |
| D | 2023-05-11 | 2023-05-10 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $35.20 | +80.7K | 99.0K | +441% | +$2.84M |
| D | 2023-05-09 | 2023-05-07 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | +6,062 | 23.0K | +36% | $0 |
| DM | 2023-05-09 | 2023-05-07+ | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $88.74 | -4,678 | 20.0K | -19% | -$415.1K |
| M | 2023-05-04 | 2023-05-03+ | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $87.96 | -874 | 16.9K | -5% | -$76.9K |
| 2023-02-21 | 2023-02-21 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $78.51 | -335 | 17.8K | -2% | -$26.3K | |
| 2023-02-17 | 2023-02-16 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | A - Grant | $0.00 | +1,941 | 18.1K | +12% | $0 | |
| 2022-05-17 | 2022-05-17 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $95.93 | -1,953 | 29.3K | -6% | -$187.4K | |
| D | 2022-05-10 | 2022-05-08 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | +14.8K | 39.9K | +59% | $0 |
| DM | 2022-05-10 | 2022-05-07+ | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $100.52 | -9,500 | 31.2K | -23% | -$954.9K |
| D | 2022-05-05 | 2022-05-04 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $105.93 | -441 | 25.9K | -2% | -$46.7K |
| DI | 2022-05-05 | 2022-04-04 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | G - Gift | $0.00 | +15.5K | 244.7K | +7% | $0 |
| D | 2022-05-05 | 2022-04-04 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | G - Gift | $0.00 | -15.5K | 21.3K | -42% | $0 |
| D | 2022-05-05 | 2022-05-03 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | A - Grant | $0.00 | +5,000 | 26.3K | +23% | $0 |
| 2022-02-22 | 2022-02-21 | EW | Edwards Lifesciences | Ullem Scott B. | CFO, CVP | F - Tax | $105.62 | -319 | 36.8K | -0.9% | -$33.7K |
Purchase Sale Sale after option exercise All abbreviations